Additional congeners of the macrolide neaumycin: structure revision and biological activity

Article metrics

Subjects

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Figure 1
Figure 2

References

  1. 1

    Baltz, R. H. Renaissance in antibacterial discovery from actinomycetes. Curr. Opin. Pharmacol. 8, 557–563 (2008).

  2. 2

    Monciardini, P., Iorio, M., Maffioli, S., Sosio, M. & Donadio, S. Discovering new bioactive molecules from microbial sources. Microb. Biotechnol 7, 209–220 (2014).

  3. 3

    Aigle, B. et al. Genome mining of Streptomyces ambofaciens. J. Ind. Microbiol. Biotechnol. 41, 251–263 (2014).

  4. 4

    Mazzei, E., Iorio, M., Maffioli, S. I., Sosio, M. & Donadio, S. Characterization of madurastatin C1, a novel siderophore from Actinomadura sp. J. Antibiot. (Tokyo) 65, 267–269 (2012).

  5. 5

    Huang, S.-X. et al. Neaumycin: a new macrolide from Streptomyces sp. NEAU-x211. Org. Lett. 14, 1254–1257 (2012).

  6. 6

    Cavalleri, B., Pagani, H., Volpe, G., Selva, E. & Parenti, F. A-16686, A new antibiotic from actinoplanes I. fermentation, isolation and premilinary physico-chemical characteristics. J. Antibiot. (Tokyo) 37, 309–317 (1984).

  7. 7

    Rolston, K. V. et al. In-vitro activity of ramoplanin (a novel lipoglycopeptide), vancomycin, and teicoplanin against gram-positive clinical isolates from cancer patients. J. Antimicrob. Chemother. 38, 265–269 (1996).

  8. 8

    Citron, D. M. et al. In vitro activities of ramoplanin, teicoplanin, vancomycin, linezolid, bacitracin, and four other antimicrobials against intestinal anaerobic bacteria. Antimicrob. Agents Chemother. 47, 2334–2348 (2003).

  9. 9

    Wagenaar, M. M., Williamson, R. T., Ho, D. M. & Carter, G. T. Structure and absolute stereochemistry of 21-hydroxyoligomycin A. J. Nat. Prod 70, 367–371 (2007).

  10. 10

    Sato, S., Iwata, F., Yamada, S. & Katayama, M. Neomaclafungins A–I: oligomycin-class macrolides from a marine-derived actinomycete. J. Nat. Prod. 75, 1974–1982 (2012).

  11. 11

    Arnoux, B. et al. X-Ray structure of the antibiotic rutamycin. Chem. Commun. 318–319 (1978).

  12. 12

    Mukhopadhyay, T. et al. Maclafungin, a new antifungal macrocyclic lactone from Actinomycete sp. Y-8521050. Tetrahedron 54, 13621–13628 (1998).

  13. 13

    Visser, J. et al. Production and isolation of the antibiotic, oligomycin. J. Biochem. Microbiol. Technol. Eng. 2, 31–48 (1960).

  14. 14

    Seto, H., Akao, H., Furihata, K. & Ōtake, N. The structure of a new antibiotic, hygrolidin. Tetrahedron Lett. 23, 2667–2670 (1982).

  15. 15

    Uyeda, M., Kondo, K. I., Ito, A., Yokomizo, K. & Kido, Y. A new antiherpetic agent produced by Streptomyces sp. strain no. 758. J. Antibiot. (Tokyo) 48, 1234–1239 (1995).

  16. 16

    Hatfield, G. M., Woodard, R. W. & Son, J.-K. Isolation and structure determination of new macrolide antibiotics. J. Nat. Prod. 55, 753–759 (1992).

  17. 17

    Werner, G., Hagenmaier, H., Drautz, H., Baumgartner, A. & Zahner, H. Metabolic products of microorganisms. 224. bafilomycins, a new group of macrolide antibiotics production, isolation, chemical structure and biological activity. J. Antibiot. (Tokyo) 37, 110–117 (1984).

  18. 18

    Hong, S. & Pedersen, P. L. ATP synthase and the actions of inhibitors utilized to study its roles in human health, disease, and other scientific areas. Microbiol. Mol. Biol. Rev. 72, 590–641 (2008).

  19. 19

    Montecalvo, M. A. Ramoplanin: a novel antimicrobial agent with the potential to prevent vancomycin-resistant enterococcal infection in high-risk patients. J. Antimicrob. Chemother. 51, 31–35 (2003).

  20. 20

    Gastaldo, L. et al. Isolation, structure determination and biological activity of A-16686 factors A′ 1, A′ 2 and A′ 3 glycolipodepsipeptide antibiotics. J. Ind. Microbiol. 11, 13–18 (1992).

  21. 21

    Pan, H. X. et al. Production of ramoplanin analogues by genetic engineering of Actinoplanes sp. J. Biotechnol Lett. 35, 1685–1692 (2013).

Download references

Acknowledgements

This work was partially supported by grant from Italian MIUR and Regione Lombardia. We are grateful to CPC Biotech (Burago di Molgora, Monza Brianza) for fermentation work, and to Ben Shen and Margherita Sosio for expert advice.

Author information

Correspondence to Matteo Simone.

Ethics declarations

Competing interests

MS, SIM, AT, EG and SD are employees of and/or hold shares of Naicons Srl.

Additional information

Supplementary Information accompanies the paper on The Journal of Antibiotics website

Supplementary information

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Simone, M., Maffioli, S., Tocchetti, A. et al. Additional congeners of the macrolide neaumycin: structure revision and biological activity. J Antibiot 68, 406–408 (2015) doi:10.1038/ja.2014.168

Download citation

Further reading